Vaccine sales?

Good luck with that! Idiot.

 

Layoffs are coming in the next 12 months. We are too heavy and have more competition coming. Time to dust off the resume.

 

Competition is looming. Too many account reps. Matter of time.

 

Vaccines is starting to feel like general pharma here at GSK. Managers leaving for different jobs both internally and externally. Lay offs are coming.

 

Afraid for your job? Data shows inside reps much more effective than their outside counterparts

 

Post #24 is spot on! The biggest problem is that gen pharma managers and executives manage and think like a large corporation. No trust, micro-management, and fear tactics. They are like a parasite that kills its host. Once they kill it they move on to the next victim. In this case, vaccines. All specialty divisions would be better served to thoroughly vet gen pharma management from infecting other parts of the organization. An easy way to do this is to NOT hire any of them! If they are soooo great, they should have no problem finding work outside our organization. This message needs to be screamed up the ranks all the way to Emma. Emma, can you hear us?

 

Emma doesn't care

 

Inside sales numbers are a joke! Data shows that you are an idiot!

 

Actually, Emma does care. She has completely revamped our executive team. Corporate culture is something she has a great passion about. Those surveys we fill out actually make it to her desk. FLLs..time to change your ways!

 

"Emma does care"
Sure she does, about herself and the people she is bringing in from GSK

 

Even this position at GSK doesn’t pay sales reps on sales. Stay away. You can win business and grow market share but you don’t get paid on results.

 

Vaccines is an okay place to be, definitely the best in GSK right now. In a major market a 6 six figure base is standard, plus whatever bonuses you end up with. With that said, there is a lot of tension surrounding the launch of new competitor hexavalent Layoffs highly probable this year.

As others have mentioned, adult reps probably wont be around much longer or they will have to have everyone be full line.

Overall, I say go for it but just don't get too comfortable.

 

You think GSK won’t have a sales force representing the biggest vaccine (Shingrix) in the history of GSK vaccines? Ped reps are overwhelmed with existing territory, and if they go full line, they would have to double the targets they see currently, assuming you add Shingrix to the mix. Adult reps will be necessary in some form or fashion.
If Hexavalent dominates, what in the heck are the Ped reps going to sell??

 

Vaccines has been back and forth several times with adult and pediatric reps. Nothing new and they can't get it right. They hire, lay off, and re-tool again. The hexavalent will overtake and as always GSK is a day late and a dollar short. Shingrix will be like Prevnar- once the majority of patients are immunized it will plateau. That is if there is ever any product available. Of course, the price will also increase making cutomers even more angry. You don't need a salesforce to sell Shingrix. We all know that. No one wants to believe it because many have their head in the sand.

 

If you want to sell or prevent MORE diseases, then you will ALWAYS need a sales force!

 

You have your head in the sand. You don't need sales force to prevent disease.

 

You clearly don’t have a head....or work in sales.

 

Well this is where some of the confusion comes in. It's not if, but when our dtap vaccine brands(3 of them) will be a fraction of what they are today. They wont go away due to existing contracts, however probably wont be sold proactively outside of small independent clinics.

I dont have the answers and never said shingrix wont have a sales force. With the decline of the dtap portfolio it honestly wouldnt be that hard to cover the adults. I'm a ped rep fyi in a major city(dense territories), so this the strategy will probably differ in large geographical territories.

 

This person is correct, whether you like it or not. Reality is inside sales is more than capable of handling 90% of the angry customer interactions about supply. "Next shipping date for your doses is x/2010".

For the other 10% of cases requiring a field rep, that's where full line can cover

 

God help us if you have any influence at corporate.